Introducing BYNFEZIA PEN™ the first-and-only multi-dose octreotide immediate release (IR) therapy

Moderator(s)

• TS

  Tania Stennett

  Sun Pharmaceuticals

Speaker(s)

• JS

  Jonathan Strosberg, MD

  Professor
  Moffitt Cancer Center